https://www.gosh.nhs.uk/news/gosh-statement-on-the-sentencing-of-a-former-member-of-staff-240521/
GOSH statement on the sentencing of a former member of staff 24.05.21
24 May 2021, 12:10 p.m.
A spokesperson for Great Ormond Street Hospital said:
"The hearings last week have shown the devastating impact of these terrible crimes and our thoughts remain with the brave victims and their families whose stories have been shared in court.
"The sentence passed today speaks to the dreadful nature of the offences, which have led to so much suffering for so many people.
“While we have heard in court that Paul Farrell did not target children at GOSH, his association with our hospital is distressing for the hospital community. We are deeply sorry that he was able to exploit his position and use our hospital to commit some of his crimes.
“Our safeguarding practices will remain rigorous and under regular review and we are actively considering whether anything more can be done to prevent crimes like this.
“Although sentence has been passed, we are keeping open the helpline we have set up with the NSPCC for anyone who has concerns relating to the case, on 0800 101 996 or through the email help@nspcc.org.uk.
You can also find our previous statement on the case published on 12 March 2021.

The Family Wall Project continues
Great Ormond Street Hospital Family Wall highlights complex mix of specialist care and all the teams involved in patient journeys.

Great Ormond Street Hospital for Children NHS Trust (GOSH) is looking for a new Non-Executive Director to focus on finance
Applications close on 17 October 2025.

Toddler who spent life in hospital is thriving after life-saving transplant
A family who spent the best part of 13 months in hospital praise their ‘new family’ at Great Ormond Street Hospital (GOSH), who cared for their son while he waited for a life-saving heart transplant.

Scientists discover clues to help children with rare muscle disease
New ground-breaking research by experts at Great Ormond Street Hospital (GOSH) and University College London (UCL) has led to an exciting discovery that could help children with the rare muscle disease, juvenile dermatomyositis (JDM).